Metformin vs Upadacitinib

## Metformin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Metformin** and **Upadacitinib**.

## Mechanism of Action

**Metformin**: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Metformin — 4-9 hours; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Metformin — C4H11N5; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Metformin — 129.1640 g/mol; Upadacitinib — 380.3700 g/mol.

**Type**: Metformin — Small molecule; Upadacitinib — Small molecule.